Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Capital Expenditures

Iovance Biotherapeutics Inc Capital Expenditures Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Capital Expenditures from 2010 to 2020.
  • Iovance Biotherapeutics Inc Capital Expenditures for the quarter ending June 06, 2020 was $-5m a 75.20% decrease of -4m year over year
  • Iovance Biotherapeutics Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $-10m a 63.14% decrease of -6m year over year
  • Iovance Biotherapeutics Inc Annual Capital Expenditures for 2019 was $-7m a 82.68% decrease of -6m from 2018
  • Iovance Biotherapeutics Inc Annual Capital Expenditures for 2018 was $-1m a 14.19% decrease of 0m from 2017
  • Iovance Biotherapeutics Inc Annual Capital Expenditures for 2017 was $-1m a -47.96% increase of 0m from 2016
Other Cash Flow Metrics:
  • Iovance Biotherapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-28m a 24.94% decrease of -7m year over year
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-16m a 52.18% decrease of -9m year over year
View Chart On Koyfin

Quarterly IOVA Capital Expenditures Data

06/2020$-5m
03/2020$-1m
12/2019$-3m
09/2019$-1m
06/2019$-1m
03/2019$-1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual IOVA Capital Expenditures Data

2019$-7m
2018$-1m
2017$-1m
2016$-2m
2015$-1m
2014$-2m
2013$0m
2011$0m